Table 1

Characteristics of the study population according to tertiles of galectin-3BP level

CharacteristicTertile 1 (n=310)Tertile 2 (n=311)Tertile 3 (n=311)
Age (years), mean (SD)16.27 (1.04)16.27 (1.02)16.05 (0.91)
Girls, n (%)144 (46.45)148 (47.59)190 (61.09)
Anthropometry
 BMI z-score, mean (SD)0.06 (1.17)0.43 (1.36)0.65 (1.36)
 Waist circumference, mean (SD)71.95 (8.60)75.00 (11.54)75.97 (12.01)
 Weight status, n (%)
  NW250 (80.65)204 (65.59)181 (58.20)
  OW40 (12.90)61 (19.61)73 (23.47)
  OB20 (6.45)46 (14.79)57 (18.33)
MetS outcomes
 MetS, n (%)8 (2.58)15 (4.82)23 (7.40)
 Center obesity, n (%)48 (15.48)92 (29.58)106 (34.08)
 Hypertension, n (%)69 (22.26)66 (21.22)82 (26.37)
 Hyperglycemia, n (%)3 (0.97)5 (1.61)5 (1.61)
 High_TG, n (%)26 (8.39)30 (9.65)26 (8.36)
 Low_HDL-C, n (%)35 (11.29)43 (13.83)48 (15.43)
Laboratory examinations
 FPG (mmol/L), median (Q1–Q3)4.28 (4.0–4.56)4.25 (3.96–4.53)4.31 (4.05–4.6)
 TG (mmol/L), median (Q1–Q3)0.71 (0.53–0.98)0.76 (0.55–1.04)0.80 (0.59–1.07)
 ALT (U/L), median (Q1–Q3)10 (8–16)10 (8–17)10 (8–17)
 AST (U/L), median (Q1–Q3)15 (13–18)16 (13–19)15 (13–18)
 ALP (U/L), median (Q1–Q3)96 (76–126)93 (77–117)93 (74–126)
 GGT (U/L), median (Q1–Q3)16 (13–20)16 (13–22)16 (13–22)
 C1q (mg/L), median (Q1–Q3)176.0 (156.6–201.4)177.6 (154.6–200.2)184.5 (167.5–209.5)
 HDL-C (mmol/L), median (Q1–Q3)1.31 (1.14–1.50)1.30 (1.11–1.51)1.28 (1.13–1.51)
 LDL-C (mmol/L), median (Q1–Q3)2.08 (1.70–2.50)2.12 (1.79–2.52)2.19 (1.80–2.58)
 Apolipoprotein A1 (g/L), median (Q1–Q3)1.30 (1.21–1.42)1.31 (1.20–1.41)1.32 (1.19–1.45)
 Apolipoprotein B (g/L), median (Q1–Q3)0.61 (0.52–0.72)0.63 (0.54–0.73)0.66 (0.56–0.76)
 Small dense low-density lipoprotein cholesterol (mmol/L), median (Q1–Q3)0.42 (0.33–0.52)0.42 (0.33–0.51)0.43 (0.34–0.53)
  • ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate aminotransferase; BMI, Body Mass Index; FPG, fasting plasma glucose; galectin-3BP, galectin-3 binding protein; GGT, gamma-glutamyl transferase; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MetS, metabolic syndrome; NW, normal weight; OB, obesity; OW, overweight; TG, triglyceride.